Sign in
Taking peopleNo phase

Comparing two foot casts for Charcot foot in people with diabetes

Compares two casting methods for Charcot neuroarthropathy of the foot in diabetes.

Key facts

Who runs it
Post Graduate Institute of Medical Education and Research, Chandigarh
Where
India1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Contact Cast Versus Posterior Slab as Offloading Modality for Charcot Neuroarthropathy
Status
Recruiting
People taking part
80 people, planned
Started
11 Dec 2024
Expected to end
31 Mar 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Total Contact Cast
  • Posterior Slab
Record updated
22 January 2025

Who can take part

The trial is looking for adults with type 2 diabetes who have active Charcot neuroarthropathy in one foot. Charcot neuroarthropathy is a foot condition with swelling, redness and warmth.

Age
18 years and above
Sex
All sexes can join
Disease stage
Active Charcot neuroarthropathy with swelling of one foot only
Earlier treatment
People who had antiresorptive agents (bone-protecting drugs) in the previous 12 months cannot join. People who took steroids in the last three months cannot join.
Main reasons for not taking part
  • An ulcer (open sore) on the foot, or both feet affected
  • Osteoporosis (T score <-2.5 at lumbar spine or hip) or gout
  • Kidney function with eGFR <30 ml/min/m2
  • Poor blood flow in the legs (ABI < 0.7)
  • Pregnant or breastfeeding women, active stomach ulcer, or active tooth decay or recent invasive dental work
Show the full registry criteria (17)Hide the full registry criteria

Who can take part

  • Type 2 Diabetes Mellitus
  • Unilateral pedal swelling
  • Active Charcot Neuroarthropathy
  • Age: 18 years and above
  • Ability to Provide Consent

Who cannot take part

  • steroid intake in the last three months,
  • those who had recently received antiresorptive agents (in the previous 12 months)
  • presence of pedal ulcer,
  • active peptic ulcer disease,
  • peripheral vascular disease (ABI < 0.7),
  • estimated glomerular filtration rate (eGFR) <30 ml/min/m2,
  • osteoporosis (T score <-2.5 at lumbar spine or hip),
  • gout,
  • active dental caries or invasive dental procedure,
  • bilateral foot involvement,
  • pregnant/ lactating women and
  • Negative consent

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Charcot neuroarthropathy

This trial is currently available in India.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Charcot neuroarthropathy (CN) is a condition in diabetic patients characterized by foot swelling, redness, and a temperature difference exceeding 2˚C compared to the other foot. The study compares two treatments: a standard knee-high, non-removable total contact cast (TCC) and a non-removable knee-high walker. Both aim to immobilize and offload the foot to promote healing. The study will involve diabetic patients with specific criteria and exclude those with conditions like foot ulcers or severe kidney issues. Patients will be randomly assigned to one of the two treatments and followed for up to a year. The primary goal is to see how many patients achieve remission within six months, with secondary goals including remission within twelve months, time to remission, quality of life, and foot health. Statistical tests will be used to analyze the data and determine the effectiveness of each treatment. The study aims to improve CN treatment and provide better options for patients.

The 2 groups in the trial

  • Total Contact Cast (TCC) Comparator ArmExisting treatment, for comparison

    standardised non-walking, non-removable, knee high, fibre-glass total contact cast

    Treatment: Total Contact Cast

  • Posterior Slab Comparator ArmExisting treatment, for comparison

    posterior non-removable knee high slab

    Treatment: Posterior Slab

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Contact Cast Versus Posterior Slab as Offloading Modality for Charcot Neuroarthropathy of Foot in Diabetes (OFFLOAD Study): A Multicentric, Non-inferiority Study
Plain-language title
Comparing two foot casts for Charcot foot in people with diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06573554, who can take part
Record updated
22 January 2025